Autonomix Medical Enters into $2.6 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules
THE WOODLANDS, TX, July 13, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) ("Autonomix” or the "Company”), a medical device company dedicated to advancing precision nerve-targeted…
Read the full articleYou might also wanna read
Autonomix (AMIX) Secures Warrant Inducement Agreement for Share Purchase
Related Stocks: AMIX
Evonik Aktie: 650 Millionen EBITDA im Q2 erwartet
Evonik schaltet in den Angriffsmodus. Der Spezialchemie-Konzern investiert massiv in den USA. Parallel dazu hebt die Führung ihre Gewinnziel
Attovia Therapeutics files for Nasdaq IPO to fund immune-disease biologics
Tao Fu's San Carlos biotech is seeking an ATTO listing before disclosing price range, share count or valuation.
Nuvation Bio Inc. Files Form 8-K with SEC Regarding Material Corporate Event
UNITED STATES
What This Cytokinetics Insider Sale Might Mean With the Stock Up 110%
Blum exercised options at $10.60 per share and immediately sold them at $82.02, capturing gains from a 122% stock surge over the past year.
Boston Scientific Aktie: 52,20 Prozent Minus seit Jahresbeginn
Ein wesentlicher Faktor für die jüngste Kursentwicklung ist die Entfernung des Medizintechnikunternehmens aus den Russell-Growth-Indizes. La
Comments
Sign in to join the conversation.
No comments yet. Be the first.